Redefining Prostate Cancer
An Innovative Guide to Diagnosis and Treatment.
Menís health specialists guide patients and caregivers in conventional and cutting-edge procedures for prostate cancer diagnosis and treatment.
Spry Publishing is pleased to announce the forthcoming release of Redefining Prostate Cancer: An Innovative Guide to Diagnosis and Treatment (Trade Paper, 978-1-938170-31-7) this October. Written by world-renowned prostate cancer specialists and menís health experts, doctors Steven Lamm, Herbert Lepor, and Dan Sperling, Redefining Prostate Cancer is a helpful resource for prostate cancer patients, as well as for family members, caregivers, friends, and hospital workers helping the patient along on the journey of coping with and understanding prostate cancer.
Redefining Prostate Cancer is the most up-to-date resource currently available and offers personal stories from patients, which encourage readers to learn how men from all walks of life have found health and improved quality of life in the course of their prostate cancer journey.
Dr. Lamm offers his views on prostate cancer from his role as a renowned menís health specialist, and heís joined by two esteemed colleagues in the field: Dr. Lepor, a leading urologist and researcher who codeveloped the nerve-sparing radical prostatectomy and has performed thousands of prostate cancer surgeries; and Dr. Sperling, an interventional radiologist specializing in advanced imaging techniques for the prostate and cutting-edge new forms of minimally invasive treatment.
Together, these experts offer patients and caregivers a wholistic, collaborative approach that results in the best individual treatment for their needs. All three experts also delve into the controversy surround the existing standards of prostate cancer screening (PSA) and provide enough information for the patients and caregivers to make the best decision for their specific case. As every patient has different goals and requirements on their journey, Redefining Prostate Cancer provides a breadth of information to answer their prostate cancer questions from diagnosis through treatment and beyond.
About the Authors
Steven Lamm, MD, is the director of the Men's Health Center at New York University Medical Center and a practicing internist. He is well-known as a frequent guest doctor on ABC-TVís The View, regularly offering his analysis and commentary on television and radio programs, including Today, Oprah, Nightline, Dateline, and Fox News. Dr. Lamm has published extensively on a variety of medical topics. His best-selling books include No Guts, No Glory (2012) and The Hardness Factor (2009).
Herbert Lepor, MD, is one of the leading experts in the field of prostate cancer. He is currently the Martin Spatz Chairman of the Department of Urology and the Director of the Smilow Comprehensive Prostate Cancer Center at the NYU Langone Medical Center in New York. He was previously appointed Chairman of Urology at NYU School of Medicine at the age of 37, the youngest chairman of a major academic urology department in the country at that time. Dr. Lepor has written more than 300 articles on the topic of prostate cancer in peer-reviewed academic publications. He has made important contributions to the screening, detection, and treatment of prostate cancer.
Dan Sperling, MD, DABR, is the Medical Director at the Sperling Prostate Center, New York, NY. A leading specialist in the diagnosis and treatment of prostate tumors through magnetic resonance imaging and laser ablation procedures, Dr. Sperling is certified by the American Board of Radiology and licensed in New York and New Jersey.